These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Lymphoscintigraphy Using Tilmanocept Detects Multiple Sentinel Lymph Nodes in Melanoma Patients. Balkin DM; Tranah GJ; Wang F; O'Donoghue C; Morell EA; Porubsky C; Nosrati M; Vaquero EM; Kim H; Carr MJ; Montilla-Soler JL; Wu MC; Torre DM; Kashani-Sabet M; Zager JS; Leong SP Cancer Control; 2023; 30():10732748231153775. PubMed ID: 36705261 [TBL] [Abstract][Full Text] [Related]
44. Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT. Brouwer OR; Buckle T; Vermeeren L; Klop WM; Balm AJ; van der Poel HG; van Rhijn BW; Horenblas S; Nieweg OE; van Leeuwen FW; Valdés Olmos RA J Nucl Med; 2012 Jul; 53(7):1034-40. PubMed ID: 22645297 [TBL] [Abstract][Full Text] [Related]
45. A Prospective Cohort Study Comparing Colorimetric and Fluorescent Imaging for Sentinel Lymph Node Mapping in Endometrial Cancer. Holloway RW; Ahmad S; Kendrick JE; Bigsby GE; Brudie LA; Ghurani GB; Stavitzski NM; Gise JL; Ingersoll SB; Pepe JW Ann Surg Oncol; 2017 Jul; 24(7):1972-1979. PubMed ID: 28265777 [TBL] [Abstract][Full Text] [Related]
46. Failure to identify sentinel lymph nodes for malignant melanoma - Outcome after over 10 years median follow up. Zlotnik O; Bernstine H; Domachevsky L; Gutman H Eur J Surg Oncol; 2019 Feb; 45(2):231-234. PubMed ID: 30343996 [TBL] [Abstract][Full Text] [Related]
47. Lymphoscintigraphy and intraoperative gamma probe-directed sentinel lymph node mapping in patients with malignant melanoma. Liu SH; Chang WC; Kao PF; Lo YF; Yang CH; Tsai CC; Tzen KY J Formos Med Assoc; 2004 Jan; 103(1):41-6. PubMed ID: 15026857 [TBL] [Abstract][Full Text] [Related]
48. Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm). Di Martino G; Crivellaro C; De Ponti E; Bussi B; Papadia A; Zapardiel I; Vizza E; Elisei F; Diestro MD; Locatelli L; Gasparri ML; Di Lorenzo P; Mueller M; Buda A J Minim Invasive Gynecol; 2017; 24(6):954-959. PubMed ID: 28571944 [TBL] [Abstract][Full Text] [Related]
49. Lymphoscintigraphy and sentinel lymph node biopsy, in cutaneous melanoma staging and treatment decisions. Jaukovic L; Sijan G; Rajović M; Kandolf-Sekulovic L; Radulovic M; Mijuskovic Z; Zolotarevski L; Ajdinovic B; Novakovic M Hell J Nucl Med; 2015; 18(2):146-51. PubMed ID: 26187215 [TBL] [Abstract][Full Text] [Related]
50. Indocyanine green fluorescence-guided sentinel lymph node biopsy in dermato-oncology. Stoffels I; von der Stück H; Boy C; Pöppel T; Körber N; Weindorf M; Dissemond J; Schadendorf D; Klode J J Dtsch Dermatol Ges; 2012 Jan; 10(1):51-7. PubMed ID: 22103392 [TBL] [Abstract][Full Text] [Related]
51. Prognostic Role of Multiple Lymphatic Basin Drainage in Sentinel Lymph Node-Negative Trunk Melanoma Patients: A Multicenter Study from the Italian Melanoma Intergroup. Ribero S; Osella-Abate S; Pasquali S; Rossi CR; Borgognoni L; Piazzalunga D; Solari N; Schiavon M; Brandani P; Ansaloni L; Ponte E; Silan F; Sommariva A; Bellucci F; Macripò G; Quaglino P Ann Surg Oncol; 2016 May; 23(5):1708-15. PubMed ID: 26597362 [TBL] [Abstract][Full Text] [Related]
52. Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm. Hagen B; Valla M; Aune G; Ravlo M; Abusland AB; Araya E; Sundset M; Tingulstad S Gynecol Oncol; 2016 Dec; 143(3):479-483. PubMed ID: 27776838 [TBL] [Abstract][Full Text] [Related]
53. Limitation of indocyanine green fluorescence in identifying sentinel lymph node prior to skin incision in cutaneous melanoma. Namikawa K; Tsutsumida A; Tanaka R; Kato J; Yamazaki N Int J Clin Oncol; 2014 Feb; 19(1):198-203. PubMed ID: 23371310 [TBL] [Abstract][Full Text] [Related]
54. Staging patients with cutaneous malignant melanoma by same-day lymphoscintigraphy and sentinel lymph node biopsy: a single-institutional experience with emphasis on recurrence. Gad D; Høilund-Carlsen PF; Bartram P; Clemmensen O; Bischoff-Mikkelsen M J Surg Oncol; 2006 Aug; 94(2):94-100. PubMed ID: 16847917 [TBL] [Abstract][Full Text] [Related]
55. Assessment of Nonradioactive Multispectral Optoacoustic Tomographic Imaging With Conventional Lymphoscintigraphic Imaging for Sentinel Lymph Node Biopsy in Melanoma. Stoffels I; Jansen P; Petri M; Goerdt L; Brinker TJ; Griewank KG; Poeppel TD; Schadendorf D; Klode J JAMA Netw Open; 2019 Aug; 2(8):e199020. PubMed ID: 31411710 [TBL] [Abstract][Full Text] [Related]
56. Indocyanine green fluorescence method for sentinel lymph node biopsy in breast cancer. Lin J; Lin LS; Chen DR; Lin KJ; Wang YF; Chang YJ Asian J Surg; 2020 Dec; 43(12):1149-1153. PubMed ID: 32143963 [TBL] [Abstract][Full Text] [Related]
57. Short-term and long-term outcomes of indocyanine green for sentinel lymph node biopsy in early-stage breast cancer. Hua B; Li Y; Yang X; Ren X; Lu X World J Surg Oncol; 2022 Aug; 20(1):253. PubMed ID: 35941602 [TBL] [Abstract][Full Text] [Related]
59. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739). Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614 [TBL] [Abstract][Full Text] [Related]
60. Interval Sentinel Lymph Nodes With the Use of Routine Lymphoscintigraphy in Extremity Melanoma. West NJ; Wadhwa S; Ayars C; Philips P; Martin RCG; Scoggins CR; McMasters KM; Egger ME J Surg Res; 2024 Jan; 293():613-617. PubMed ID: 37837816 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]